Brent Hatzis-Schoch, See Remarks at Black Diamond Therapeutics, Inc. (BDTX), sold 7,861 shares at $32.61 ($257K) on 2020-10-12, disclosed to the SEC on 2020-10-14.
Open-market sale of $257k BDTX by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.61 | 3,783 | $123K | 48.1% |
| 2 | $32.61 | 3,783 | $123K | 48.1% |
| 3 | $33.75 | 295 | $10K | 3.9% |
| Total | $32.65 avg | 7,861 | $257K | 100% |
| Filing → |
| BDTX | SELL | 2021-03-16 | $215K | — | Filing → |
| BDTX | SELL | 2021-02-12 | $214K | — | Filing → |
| BDTX | SELL | 2021-01-14 | $506K | — | Filing → |